Zoonotic Diseases and Spillover Biology

Introduction to Zoonoses

Zoonoses are infectious diseases transmitted from animals to humans—either through direct contact, intermediate animal hosts, arthropod vectors, or environmental contamination. Over 60% of human infectious diseases are zoonotic in origin; approximately 75% of emerging infectious diseases originate from animals. Major zoonotic pandemics include HIV/AIDS (estimated spillover from chimpanzees in Central Africa ~1920s), the 1918 influenza pandemic (probable avian origin), SARS-CoV-1 (bats via civets), MERS-CoV (bats via dromedary camels), Ebola (bats), and SARS-CoV-2 (likely bats via possible intermediate host). Understanding the ecological and molecular biology of zoonotic spillover is fundamental to pandemic preparedness.

Spillover—the transmission of a pathogen from a reservoir animal host to a new host species—requires ecological contact between the reservoir and new host, sufficient pathogen exposure, and the ability of the pathogen to replicate in and be transmitted by the new host. Most spillovers are dead ends—the pathogen fails to sustain transmission in the new host population. Sustained human-to-human transmission (pandemic potential) requires additional adaptations to the new host's cellular machinery, immune evasion mechanisms, and transmissibility. The density of spillover events driven by human encroachment into wildlife habitats, wildlife markets, and deforestation creates a continuous funnel through which pandemic-capable pathogens can emerge.

Reservoir Biology

Bat Reservoirs

Bats are disproportionate reservoirs for viruses with human pandemic potential—harbouring lineages of coronaviruses, filoviruses, henipah viruses, lyssaviruses, and many other viruses. Bat immune systems tolerate high viral loads without lethal disease through evolutionary adaptations including constitutive low-level interferon activity providing a stable antiviral state, dampened NLRP3 inflammasome activation reducing inflammatory immunopathology, and high metabolic activity during flight that may provide a tolerance-rather than clearance-based immune strategy. Bat colonies create opportunities for virus amplification and diversity; migration distributes viruses over large geographic areas. SARS-related coronaviruses circulate in Rhinolophus (horseshoe bat) populations in Southeast Asia with genetic diversity far exceeding the single strain causing the SARS epidemic.

Vector-Borne Zoonoses

Arthropod vectors—mosquitoes, ticks, sandflies, fleas—transmit pathogens between animal reservoir hosts and humans. Aedes aegypti mosquitoes transmit Dengue, Zika, Chikungunya, and Yellow Fever viruses; they are exquisitely adapted to human environments, breeding in urban water containers and preferring human blood. Climate change is expanding Aedes aegypti range northward in both hemispheres, increasing geographic risk of vector-borne zoonoses. Ixodes tick-borne diseases (Lyme disease, tick-borne encephalitis, Powassan virus) are expanding as deer populations increase and winters warm. Understanding vector biology, competence (ability to transmit specific pathogens), and capacity (vector abundance × competence) guides vector control and risk mapping.

Host Range and Viral Adaptation

Receptor Binding and Host Tropism

Cellular receptor binding is a key determinant of host range. SARS-CoV-2 Spike protein binds ACE2 with higher affinity than SARS-CoV-1; ACE2 ortholog comparisons across species predicted susceptibility of cats, ferrets, mink, and deer—confirmed by natural and experimental infections. H5N1 avian influenza hemagglutinin binds alpha-2,3-linked sialic acids (dominant in avian respiratory tract and human lower respiratory tract); human seasonal influenza HA binds alpha-2,6 linked sialic acids (dominant in human upper respiratory tract). H5N1's failure to efficiently transmit human-to-human is partly attributable to its receptor binding preference restricting replication to the lower respiratory tract from which aerosol transmission is less efficient.

Recombination and Reassortment

RNA viruses with segmented genomes (influenza, Bunyaviruses) undergo reassortment—exchanging genomic segments when two strains co-infect the same cell. The 2009 H1N1 pandemic virus was a reassortant of human, avian, and swine influenza segments assembled in a North American swine IAV population. Antigenic shift (segment exchange creating novel hemagglutinin-neuraminidase combinations against which most humans lack immunity) is the mechanism of pandemic influenza generation, as opposed to antigenic drift (gradual mutation accumulating in existing HA/NA). Surveillance of swine, avian, and equine influenza gene segments circulating near human populations identifies potential pandemic precursor viruses, guiding pre-pandemic vaccine development.

Pandemic Preparedness

Pandemic preparedness requires surveillance at the human-animal interface (One Health approach), platforms for rapid vaccine and therapeutic development, international coordination frameworks, and risk communication. CEPI (Coalition for Epidemic Preparedness Innovations) funds vaccine development for priority pathogens and maintains 100-days vaccine development mission—developing a first GMP vaccine within 100 days of pathogen identification. Prototype pathogen approach develops vaccines against representative family members (betacoronavirus spike vaccines) enabling rapid adaptation when novel outbreak viruses emerge. WHO-coordinated global influenza surveillance maintains year-round strain characterisation enabling seasonal vaccine formulation and monitoring pandemic-capable strains.

Examples and Applications

Example 1: SARS-CoV-2 Origin Investigation

The SARS-CoV-2 origin remains debated between natural zoonotic spillover (bat origin given close SARS-related coronavirus relatives, possible Rhinolophus bat reservoir in Yunnan) and laboratory-linked origin hypotheses. Bat SARS-related CoV databases from Yunnan caves contain viruses up to 96.2% genetically similar (RaTG13). The furin cleavage site in SARS-CoV-2 Spike is absent in known bat CoVs and enhances human cell tropism. Origins investigation requires systematic sampling of wildlife at the putative spillover location—Wuhan live animal markets and surrounding areas—and transparent reporting of early case data, sequences, and laboratory records. SARS-CoV-1's spillover via civet cats from bat reservoirs in Guangdong markets provides the precedent model for investigation methodology.

Example 2: Ebola Outbreak Response

Ebola virus disease has caused multiple outbreaks since its 1976 discovery in DRC. The 2014-16 West Africa epidemic—unprecedented in scale (28,000 cases, 11,000 deaths) due to dense urban transmission chains in Guinea, Sierra Leone, and Liberia—drove vaccine development. VSV-ZEBOV (rVSV-ZEBOV, Ervebo) was evaluated in a ring vaccination trial in Guinea using innovative epidemic-adapted study design—vaccinating contact rings around confirmed cases—showing 100% efficacy against confirmed Ebola. The vaccine was deployed for outbreak control in subsequent DRC outbreaks (2018-2020). Bat frugivore species (Pteropus bats in Africa, Mops condylurus in some studies) are suspected reservoirs. Market banning and bushmeat handling restriction reduce spillover risk.

Example 3: Nipah Virus Emergence

Nipah virus (NiV) is a bat-borne paramyxovirus first identified in Malaysia in 1998-99 where it caused fatal encephalitis in pig farmers through pig reservoir amplification. Pteropus fruit bats (flying foxes) are the natural reservoir, shedding virus in urine, faeces, and saliva—contaminating date palm sap in Bangladesh where direct bat-to-human spillover causes periodic outbreaks (case fatality rate 40-75% with occasional human-to-human transmission). The proximity of Pteropus roost trees to date palm cultivation and the local practice of collecting raw sap overnight drives spillover. Tree guards preventing bat access to sap collectors significantly reduced NiV exposure in Bangladesh. No approved vaccine exists; phase II trials are ongoing with IAVI NiV vaccine candidates.

Example 4: H5N1 Avian Influenza Pandemic Risk

H5N1 highly pathogenic avian influenza (HPAI) has circulated in birds since 1996 and periodically spills into humans via direct bird contact—case fatality rate approximately 60% in reported human cases. The 2024 outbreak of H5N1 in North American dairy cattle (novel host for HPAI H5N1) with human cases among dairy farm workers raised pandemic concern—cattle represent higher-exposure agricultural workers than wild birds. Ferret transmission studies established that acquiring human receptor binding preference (Q226L, G228S HA mutations) in addition to further adaptations could enable airborne transmission. WHO collaborating centres maintain pre-pandemic H5N1 vaccine candidates; BARDA maintains H5N1 vaccine stockpiles enabling rapid scale-up if pandemic emergence occurs.

Example 5: Lyme Disease Ecology

Lyme disease (Borrelia burgdorferi) involves a complex transmission cycle: Peromyscus white-footed mice as the main reservoir in northeast North America; Ixodes scapularis black-legged ticks as vectors; white-tailed deer as tick reproductive hosts (not Borrelia reservoirs). Deer population increases from reduced hunting and suburban forest fragmentation have driven Lyme disease expansion—now the most common vector-borne disease in North America (~476,000 US cases annually). Increasing temperatures extend the tick active season and expand geographical range northward into Canada. Lyme disease vaccines (OspA-based) were successfully used in the late 1990s but withdrawn due to commercial reasons and are being redeveloped with modern mRNA vaccine platforms in current clinical trials.

Example 6: MERS-CoV and Camel-to-Human Transmission

Middle East Respiratory Syndrome CoV (MERS-CoV) spills into humans from dromedary camels in the Arabian Peninsula—where camels seroprevalence for MERS-CoV antibodies reaches 90% without clinical disease. Camel-to-human and human-to-human (in healthcare settings) transmissions occur; the basic reproduction number R0 in humans is approximately 0.5 (insufficient for pandemic spread without amplification events in healthcare settings). Phylogenetic analysis traces bat ancestor-origin MERS lineage implanted in camels in Africa centuries ago, then spreading to Middle East via livestock trade. Camel vaccination studies using recombinant spike vaccines reduced camel shedding—a One Health intervention targeting the animal reservoir to reduce human spillover risk.

Example 7: Pandemic Influenza Preparedness

Global influenza surveillance—WHO Global Influenza Surveillance and Response System (GISRS) with 150 national laboratories—monitors circulating strains, identifies novel reassortants, and annually recommends northern and southern hemisphere seasonal vaccine strain compositions. WHO's Global Action Plan for Influenza Vaccines produced stockpiles of H5N1, H7N9, and other pandemic candidate strains maintained at BARDA and national stockpiles. mRNA platform enables faster adapted vaccine formulation than egg-based production (months vs. 6 months). Pandemic influenza modelling using age-structure, mobility, and vaccination coverage data guides non-pharmaceutical intervention strategies and vaccine deployment priorities for anticipated pandemic scenarios.

Example 8: Bushmeat and Wildlife Markets

Wildlife markets (live animal markets, wet markets) and bushmeat hunting create intense human-wildlife contact amplifying spillover risk. The global wildlife trade—estimated $23 billion annually through both legal and illegal trade—moves animals long distances across species barriers enabling pathogen mixing and amplification. HIV, SARS-CoV-1, SARS-CoV-2, Ebola, and monkeypox are all linked to wildlife contact events. Reducing highest-risk wildlife contact requires market regulation (separating wild from domestic animals, hygiene standards, reducing live animal sales), bushmeat monitoring and testing, and community-based alternatives to bushmeat dependency in forest-edge communities. The One Health framework explicitly connects human, animal, and environmental health in surveillance and intervention design.

Try it live

Everything above runs in your browser — open Zoonotic Spillover Simulator and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.